• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合诊断网络构建揭示了 4 个基因panel 和 5 个癌症特征驱动乳腺癌异质性。

Integrated diagnostic network construction reveals a 4-gene panel and 5 cancer hallmarks driving breast cancer heterogeneity.

机构信息

National Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi, China.

The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China.

出版信息

Sci Rep. 2017 Jul 28;7(1):6827. doi: 10.1038/s41598-017-07189-6.

DOI:10.1038/s41598-017-07189-6
PMID:28754978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5533795/
Abstract

Breast cancer encompasses a group of heterogeneous diseases, each associated with distinct clinical implications. Dozens of molecular biomarkers capable of categorizing tumors into clinically relevant subgroups have been proposed which, though considerably contribute in precision medicine, complicate our understandings toward breast cancer subtyping and its clinical translation. To decipher the networking of markers with diagnostic roles on breast carcinomas, we constructed the diagnostic networks by incorporating 6 publically available gene expression datasets with protein interaction data retrieved from BioGRID on previously identified 1015 genes with breast cancer subtyping roles. The Greedy algorithm and mutual information were used to construct the integrated diagnostic network, resulting in 37 genes enclosing 43 interactions. Four genes, FAM134B, KIF2C, ALCAM, KIF1A, were identified having comparable subtyping efficacies with the initial 1015 genes evaluated by hierarchical clustering and cross validations that deploy support vector machine and k nearest neighbor algorithms. Pathway, Gene Ontology, and proliferation marker enrichment analyses collectively suggest 5 primary cancer hallmarks driving breast cancer differentiation, with those contributing to uncontrolled proliferation being the most prominent. Our results propose a 37-gene integrated diagnostic network implicating 5 cancer hallmarks that drives breast cancer heterogeneity and, in particular, a 4-gene panel with clinical diagnostic translation potential.

摘要

乳腺癌包括一组异质疾病,每种疾病都与不同的临床意义相关。已经提出了数十种能够将肿瘤分类为具有临床相关性亚组的分子生物标志物,尽管这些标志物在精准医学中做出了重要贡献,但它们也使我们对乳腺癌亚分型及其临床转化的理解变得更加复杂。为了解码具有乳腺癌诊断作用的标志物网络,我们通过整合 6 个公共基因表达数据集和从 BioGRID 检索到的蛋白质相互作用数据,构建了诊断网络,这些数据是基于先前确定的 1015 个具有乳腺癌亚分型作用的基因。我们使用贪婪算法和互信息构建了综合诊断网络,结果包含 43 个相互作用的 37 个基因。通过层次聚类和支持向量机和 k 最近邻算法的交叉验证,我们发现 4 个基因(FAM134B、KIF2C、ALCAM、KIF1A)与最初的 1015 个基因具有可比的亚分型效果,具有相似的亚分型效果。通路、基因本体和增殖标志物富集分析共同表明,有 5 个主要的癌症特征标志驱动着乳腺癌的分化,其中促进不受控制的增殖是最显著的。我们的研究结果提出了一个由 37 个基因组成的综合诊断网络,其中包含 5 个癌症特征标志,这些标志驱动着乳腺癌的异质性,特别是一个具有临床诊断转化潜力的 4 基因面板。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/342c0aab0c2e/41598_2017_7189_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/b5bd31269e86/41598_2017_7189_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/a5d438ae4f5f/41598_2017_7189_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/a8c33c750c7e/41598_2017_7189_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/4ffffefe6146/41598_2017_7189_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/5c80685480a9/41598_2017_7189_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/6fe72f38e4b3/41598_2017_7189_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/3254360906c2/41598_2017_7189_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/342c0aab0c2e/41598_2017_7189_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/b5bd31269e86/41598_2017_7189_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/a5d438ae4f5f/41598_2017_7189_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/a8c33c750c7e/41598_2017_7189_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/4ffffefe6146/41598_2017_7189_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/5c80685480a9/41598_2017_7189_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/6fe72f38e4b3/41598_2017_7189_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/3254360906c2/41598_2017_7189_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9183/5533795/342c0aab0c2e/41598_2017_7189_Fig8_HTML.jpg

相似文献

1
Integrated diagnostic network construction reveals a 4-gene panel and 5 cancer hallmarks driving breast cancer heterogeneity.综合诊断网络构建揭示了 4 个基因panel 和 5 个癌症特征驱动乳腺癌异质性。
Sci Rep. 2017 Jul 28;7(1):6827. doi: 10.1038/s41598-017-07189-6.
2
Association between two polymorphisms of CD166/ALCAM gene and breast cancer risk in Chinese women.CD166/ALCAM基因的两个多态性与中国女性乳腺癌风险之间的关联。
Breast Cancer Res Treat. 2011 Sep;129(2):645-6; author reply 647. doi: 10.1007/s10549-011-1528-9. Epub 2011 Apr 22.
3
Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population.CD166/ALCAM 基因功能多态性与中国人群乳腺癌发病风险增加相关。
Breast Cancer Res Treat. 2011 Jul;128(2):527-34. doi: 10.1007/s10549-011-1365-x. Epub 2011 Feb 4.
4
Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.激活的白细胞细胞黏附分子过表达在乳腺癌细胞系和临床肿瘤组织中的生物学作用。
Breast Cancer Res Treat. 2011 Sep;129(2):347-60. doi: 10.1007/s10549-010-1219-y. Epub 2010 Oct 23.
5
Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.活化白细胞细胞黏附分子 (ALCAM) 与 ALCAM 基因启动子甲基化在乳腺癌中的预后意义。
Molecules. 2018 Jan 9;23(1):131. doi: 10.3390/molecules23010131.
6
Cancer stem cell transcriptome landscape reveals biomarkers driving breast carcinoma heterogeneity.癌症干细胞转录组全景揭示了驱动乳腺癌异质性的生物标志物。
Breast Cancer Res Treat. 2021 Feb;186(1):89-98. doi: 10.1007/s10549-020-06045-y. Epub 2021 Jan 3.
7
Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells.半乳糖凝集素-8与活化白细胞细胞黏附分子(ALCAM/CD166)的糖基化依赖性结合促进其在乳腺癌细胞表面的分离。
Biochim Biophys Acta. 2016 Oct;1860(10):2255-68. doi: 10.1016/j.bbagen.2016.04.019. Epub 2016 Apr 26.
8
ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.ALCAM,活化白细胞细胞黏附分子,影响乳腺癌细胞的侵袭特性,这与骨转移有潜在联系。
Anticancer Res. 2010 Apr;30(4):1163-8.
9
[Expression of activated leukocyte cell adhesion molecule in breast cancer. Predictability of the response to taxane-free chemotherapy].[活化白细胞黏附分子在乳腺癌中的表达。无紫杉烷化疗反应的可预测性]
Pathologe. 2008 Nov;29 Suppl 2:347-52. doi: 10.1007/s00292-008-1080-5.
10
ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.ALCAM/CD166 是 TGF-β 的反应性标志物,也是前列腺癌骨转移的功能调节剂。
Cancer Res. 2014 Mar 1;74(5):1404-15. doi: 10.1158/0008-5472.CAN-13-1296. Epub 2014 Jan 2.

引用本文的文献

1
Excessive ER-phagy mediated by FAM134B contributes to trophoblast cell mitochondrial dysfunction in preeclampsia.FAM134B 介导的内质网自噬过度导致子痫前期滋养细胞线粒体功能障碍。
Acta Biochim Biophys Sin (Shanghai). 2024 May 22;56(10):1446-1459. doi: 10.3724/abbs.2024065.
2
Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation.臭椿酮治疗结直肠癌的作用机制阐释:网络药理学、生物信息学分析与实验验证的整合
Front Pharmacol. 2024 Feb 7;15:1355644. doi: 10.3389/fphar.2024.1355644. eCollection 2024.
3

本文引用的文献

1
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping.乳腺癌细胞系分类及其与乳腺肿瘤亚型的相关性。
J Cancer. 2017 Sep 12;8(16):3131-3141. doi: 10.7150/jca.18457. eCollection 2017.
2
The prognostic significance of Cdc6 and Cdt1 in breast cancer.Cdc6 和 Cdt1 在乳腺癌中的预后意义。
Sci Rep. 2017 Apr 20;7(1):985. doi: 10.1038/s41598-017-00998-9.
3
Novel FAM134B mutations and their clinicopathological significance in colorectal cancer.新型FAM134B突变及其在结直肠癌中的临床病理意义
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker.
KIF2C/MCAK 作为一种预后生物标志物及其在恶性进展和癌症患者预后中的致癌潜能的系统评价和荟萃分析。
Crit Rev Clin Lab Sci. 2024 Sep;61(6):404-434. doi: 10.1080/10408363.2024.2309933. Epub 2024 Feb 12.
4
Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives.选择性自噬在癌症中的作用:机制、治疗意义及未来展望。
Mol Cancer. 2024 Jan 24;23(1):22. doi: 10.1186/s12943-024-01934-y.
5
Crosstalk between KIF1C and PRKAR1A in left atrial myxoma.左心房黏液瘤中 KIF1C 与 PRKAR1A 的串扰。
Commun Biol. 2023 Jul 14;6(1):724. doi: 10.1038/s42003-023-05094-5.
6
MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer Models.MCAK抑制剂在三阴性乳腺癌模型中诱导非整倍体产生。
Cancers (Basel). 2023 Jun 23;15(13):3309. doi: 10.3390/cancers15133309.
7
Metabolic adaption of cancer cells toward autophagy: Is there a role for ER-phagy?癌细胞对自噬的代谢适应:内质网自噬是否发挥作用?
Front Mol Biosci. 2022 Aug 3;9:930223. doi: 10.3389/fmolb.2022.930223. eCollection 2022.
8
The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers.活化白细胞黏附分子(ALCAM)/CD166在人类实体癌中的临床及诊疗价值
Cancers (Basel). 2021 Oct 15;13(20):5187. doi: 10.3390/cancers13205187.
9
TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination.TBX15/miR-152/KIF2C通路通过促进丙酮酸激酶M2(PKM2)泛素化来调节乳腺癌对阿霉素的耐药性。
Cancer Cell Int. 2021 Oct 18;21(1):542. doi: 10.1186/s12935-021-02235-w.
10
Advances in ER-Phagy and Its Diseases Relevance.内质网自噬及其疾病相关性的研究进展。
Cells. 2021 Sep 6;10(9):2328. doi: 10.3390/cells10092328.
Hum Genet. 2017 Mar;136(3):321-337. doi: 10.1007/s00439-017-1760-4. Epub 2017 Jan 31.
4
MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM.微小RNA-148a和微小RNA-152通过下调活化白细胞黏附分子降低雌激素受体阳性乳腺癌中的他莫昔芬耐药性。
Biochem Biophys Res Commun. 2017 Feb 5;483(2):840-846. doi: 10.1016/j.bbrc.2017.01.012. Epub 2017 Jan 4.
5
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes.癌症特征、生物标志物与乳腺癌分子亚型
J Cancer. 2016 Jun 23;7(10):1281-94. doi: 10.7150/jca.13141. eCollection 2016.
6
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients.利用1065例患者的转录组数据对胃癌生存相关生物标志物进行交叉验证。
Oncotarget. 2016 Aug 2;7(31):49322-49333. doi: 10.18632/oncotarget.10337.
7
Identification of Novel FAM134B (JK1) Mutations in Oesophageal Squamous Cell Carcinoma.鉴定食管鳞状细胞癌中新型 FAM134B(JK1)突变。
Sci Rep. 2016 Jul 4;6:29173. doi: 10.1038/srep29173.
8
Breast cancer intrinsic subtype classification, clinical use and future trends.乳腺癌内在亚型分类、临床应用及未来趋势。
Am J Cancer Res. 2015 Sep 15;5(10):2929-43. eCollection 2015.
9
Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.基于组合癌症特征的基因签名集的鉴定和构建,以预测 II 期结直肠癌的复发和化疗获益。
JAMA Oncol. 2016 Jan;2(1):37-45. doi: 10.1001/jamaoncol.2015.3413.
10
Regulation of endoplasmic reticulum turnover by selective autophagy.内质网周转率的选择性自噬调控。
Nature. 2015 Jun 18;522(7556):354-8. doi: 10.1038/nature14498. Epub 2015 Jun 3.